ChatAbout Prof. Anthony D.Ho
- Prof. Anthony D.Ho is a Hematologist-Oncologist in Germany with a thriving experience of over 46+ years.
- He is a member of the Central Ethics Committee for Stem Cell Research of the National Parliament, (Bundestag), Berlin since 2002, and the Heidelberg Academy of Sciences since 2003.
- He received his medical education at the Universities of Innsbruck, Austria, and also Heidelberg, Germany from 1968 to 1974. He also has an MD degree and specialist training in hematology and medical oncology at the Ruprecht-Karls-University from 1975 to 1981.
- Later, he worked as a full professor in Internal Medicine at the University of Ottawa, Canada (1990-1992) and tenured professor at the University of California, San Diego (UCSD) (1992-1998).
- His areas of interest are the treatment of leukemias and lymphoma, stem cell transplant (autologous, allogenic & umbilical cord blood transplant), bleeding disorders, blood clots, anemia, etc.
- He has written for various national and international journals along with attending seminars on a regular basis.
Hospital
Hospital University Hospital Heidelberg
Location
LocationHeidelberg, Germany
Special Interest
Bone marrow failure syndrome Autologous transplant for multiple myeloma Hemoglobinopathies for thalassemias and sickle cell disease Management of clots and Bleeding problems Immunodeficiency work up
Work Experience of Prof. Anthony D.Ho
Professor, University of Ottawa
Director, Northeastern Ontario Regional Cancer Center, Sudbury, Ontario
Director, University of California, San Diego, California
Prof. Anthony D.Ho's
- Graduation, 1968, University of Innsbruck, Austria
- Graduation, 1970, University of Heidelberg, Germany
1. Gottschling S, Saffrich R, Seckinger A, Krause U, Horsch K, Miesala K, Ho AD (2007): Human Mesenchymal Stroma Cells Regulate Initial Self-Renewing Divisions of Hematopoietic Progenitor Cells by a β1-Integrin-Dependent Mechanism. Stem Cells 25:798-806
2. Giebel B, Zhang T, Beckmann J, Spanholtz J, Wernet P, Ho AD, Punzel M. Primitive human hematopoietic cells give rise to differentially specified daughter cells upon their initial cell division. Blood 107:2146-2152, 2006
3. Wagner W. Saffrich R, Wirkner U, Eckstein V, Blake J, Ansorge A, Schwager C, Wein F, Miesala K, Ansorge W, Ho AD: Hematopoietic Progenitor Cells and Cellular Microenvironment: Behavioral and Molecular Changes upon Interaction, Stem Cells, 23:1180-1191, 2005.
4. Munder M, Mollinedo F, Calafat J, Canchado J, Gil-Lamaignere C, Fuentes JM, Luckner C, Doschko G, Soler G, Eichmann K, Müller FM, Ho AD, Goerner M, Modolell M. Arginase I is constitutively expressed in human granulocytes and participates in a fungicidal activity, Blood 105:2549-2556, 2005.
5. Neben K, Giesecke C, Schweizer S, Ho AD, Kramer A: Centrosome aberrations in acute myeloid leukemia are correlated with cytogenetic risk profile, Blood 101:289- 291, 2003
Wondering where to start?
(Get Free opinion, Quote, Medical Visa Invitation and Assistance at every step of your treatment.)
